• Private Equity Firm

    Shavit Capital is an investment firm that specializes in late-stage investments in Israeli and Israeli-related companies.

    Shavit Capital has over $400 million under management across five separate private equity funds. Shavit Capital was founded in 2008 and the fifth fund was raised in 2019.  The Funds invest in Israeli companies with proven technologies, products, markets and strong management teams. The Funds invest in equity mezzanine or bridge rounds in companies which subsequently expect to raise relatively larger amounts pursuant to an IPO on a major international public exchange or a dual listing of a company that trades on the Tel Aviv Stock Exchange.

    Shavit Capital also invests in other late-stage opportunities, especially through PIPEs (Private Investment in Public Equites) of Israeli publicly-traded companies.

  • Company News

    Israeli-American Gamida hits goal in phase 3 blood cancer trial
    May 13, 2020
    Cell therapy firm boosts odds for blood cancer patients as key trial succeeds
    May 12, 2020
    Ayala Pharmaceuticals raises $55m in Nasdaq IPO
    May 10, 2020
    A Hard Target Needs a Sharper DaRT
    May 1, 2020
    Syqe Medical Named to Fast Company's Annual List of the World's Most Innovati
    March 11, 2020
    PolyPid Announces the Initiation of a Phase 3 Clinical Trial of D-PLEX100 for
    February 27, 2020
    How Israeli technology saved 78-year-old Leah from skin cancer
    February 13, 2020
    Alpha DaRT treatment proves a success in first-in-human trial
    January 10, 2020
    Gamida Cell Announces Completion of Patient Enrollment in Ongoing Phase 3 Cli
    January 2, 2020
    Israel's alpha radiation treatment shows tumor shrinkage in 100% of cases
    December 27, 2019